AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Jul 22, 2022

A glimpse into dermatology’s bright future

Panelists spotlight what’s new and emerging.


Left to right: April W. Armstrong, MD, MPH, FAAD, Hensin Tsao, MD, PhD, FAAD, and Sandy Sharon Tsao, MD, FAAD.
Left to right: April W. Armstrong, MD, MPH, FAAD, Hensin Tsao, MD, PhD, FAAD, and Sandy Sharon Tsao, MD, FAAD.

F001 – Future of Dermatology Symposium
Thursday, July 21 | 1-5 p.m.

You don’t need a crystal ball to know the future is bright for dermatology.  A look at recent, groundbreaking scientific developments in dermatologic research and its application to clinical practice were among the topics of discussion regarding dermatology’s future during Thursday’s session, F001 – Future of Dermatology Symposium.

Session co-directors Hensin Tsao, MD, PhD, FAAD, director of the Melanoma and Pigmented Lesion Center, the melanoma genetics program and the department of dermatology at Massachusetts General Hospital in Boston; April W. Armstrong, MD, MPH, FAAD, associate dean of clinical research at Keck School of Medicine at the University of Southern California in Los Angeles; and Sandy Sharon Tsao, MD, FAAD, a dermatologist at Massachusetts General Hospital in Boston, led an impressive panel discussion of dermatologic promise. Among the panel of experts was Aaron S. Farberg, MD, FAAD, a dermatologic surgeon at Baylor University Medical Center in Dallas, who discussed a prognostic test proving successful in the treatment of cutaneous melanoma patients.

“Current staging systems for cutaneous melanoma have inherent limitations, and we should best understand our patients’ individual risk to drive our management. This is personalized medicine,” Dr. Farberg said.

Future Of Derm Crop

Bring on the cold

New York City dermatologist Peter C. Friedman, MD, PhD, FAAD, detailed current achievements and new trends in clinical dermatologic cold plasma research. According to Dr. Friedman, cold plasma’s “future promise of exciting, emerging technology” has applications in dermatologic wound healing and is now licensed in Germany to be used in the treatment of chronic wounds. 

“While the pathogenesis of chronic wounds is complex, the presence of bacteria does play a role. Plasma has a well-documented inhibitory effect on bacteria, and this is what initially led to the idea of using cold plasma to reduce bacterial load of wounds and thus facilitate healing,” Dr. Friedman said.

Similarly, cold plasma has shown promise in the treatment of other dermatologic conditions, he said, including actinic keratoses, viral warts, hair loss, and multiple others. 

The good news is that cold plasma has a variety of effects on living tissues and medical treatment applications. According to Dr. Friedman, cold plasma is affordable to create at room temperature and under atmospheric pressure, making it ideal to be applied to the surface of the skin without discomfort, pain, or known harmful effects. 

Dr. Friedman and his team pioneered the use of cold plasma to treat actinic keratosis, followed by other research teams worldwide. Dr. Friedman presented the first cases of using cold plasma to successfully treat early skin cancers, in situ squamous cell carcinomas.

“Plasma medicine is just taking its first baby steps, but it shows promise for the treatment of various skin diseases,” he said. “Extensive laboratory research and recent proof-of-concept clinical trials raise the hope that plasma may be the answer to some of the most stubborn problems in dermatology by destroying hard-to-treat bacteria or fungi, causing selective cell death in malignancies, and inducing tissue regeneration.”

Visit AAD DermWorld Meeting News Central for more articles.

 

Interesting Stories
Prurigo Nodularis and Atopic Dermatitis:
Presented by Sanofi and Regeneron Pharmaceuticals, Inc.
Prurigo Nodularis and Atopic Dermatitis:
Janssen-Sponsored Symposium
Presented by Janssen Biotech, Inc.
Janssen-Sponsored Symposium
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Presented by Neutrogena
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
Advancing Therapeutic Conversations
Presented by AbbVie
Advancing Therapeutic Conversations
Join Us to Learn More About SOTYKTU<sup>TM</sup> (deucravacitinib):
Presented by Bristol Myers Squibb
Join Us to Learn More About SOTYKTUTM (deucravacitinib):
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Presented by Pfizer Inc.
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
More in 2022 AAD Innovation Academy
Keira L. Barr, MD, FAAD
2022 AAD Innovation Academy
Unlocking the secrets of mind-body therapy
Jul 29, 2022
Robert T. Brodell, MD, FAAD
2022 AAD Innovation Academy
Fox Lecture: Access belongs to everyone
Jul 29, 2022
Img 9508
2022 AAD Innovation Academy
AAD debuts Innovation Academy in Vancouver
Jul 29, 2022
Edit Olasz Harken, MD, PhD, FAAD
2022 AAD Innovation Academy
Your name can be your skin care brand
Jul 29, 2022
Pearl E. Grimes, MD, FAAD
2022 AAD Innovation Academy
Kelly Lectureship traces advances in pigmentary diseases
Jul 29, 2022
Pearl Grimes, MD, FAAD, and Robert T. Brodell, MD, FAAD, FRCP
2022 AAD Innovation Academy
Saturday’s named lectureships take the stage
Jul 23, 2022
Jason B. Lee, MD, FAAD
2022 AAD Innovation Academy
How are your diagnostic skills?
Jul 23, 2022
Lindsay Strowd, MD, FAAD
2022 AAD Innovation Academy
Consultive dermatology plugs in post pandemic
Jul 23, 2022
Mehdi Rashighi, MD, FAAD
2022 AAD Innovation Academy
Game-changing new treatments evolve for dermatologic conditions
Jul 23, 2022
Carolyn Goh, MD, FAAD
2022 AAD Innovation Academy
New approaches to managing hair disorders
Jul 23, 2022
So Yeon Paek, MD, FAAD
2022 AAD Innovation Academy
Laser focused
Jul 22, 2022
Brett A. King, MD, PhD, FAAD
2022 AAD Innovation Academy
JAK inhibitors revolutionize dermatology
Jul 22, 2022
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.